Health Ministry reduces COVID-19 booster dose gap to 6 months for all adults MD Bureau7 July 2022 3:00 PM ISTThe COVID precaution dose for all beneficiaries from 18-59 years will be administered after completion of 6 months or 26 weeks from the date of...
USFDA recommends COVID booster targeting Omicron subvariants Ruchika Sharma2 July 2022 1:45 PM ISTThe Omicron BA.4 and BA.5 variants, currently driving the fresh wave of Covid cases globally, are known to evade vaccine induced immunity.
Maternal vaccination lowers risk of COVID-19-associated hospitalization in infants: NEJM Dr. Hiral patel30 Jun 2022 7:30 PM ISTUSA: Completion of a 2-dose primary mRNA COVID-19 vaccination series during pregnancy is associated with a reduced risk of hospitalization for...
EU regulator begins review of Bavarian Nordic smallpox vaccine Imvanex for monkeypox Ruchika Sharma29 Jun 2022 1:00 PM ISTMost monkeypox patients experience only fever, body aches, chills and fatigue.
COVID-19: DCGI nod to Gennova's indigenous mRNA vaccine for emergency use in 18 years and above; SII's Covovax for 7-11 years Ruchika Sharma29 Jun 2022 10:00 AM ISTGennova developed the mRNA vaccine with the support of the Department of Biotechnology (DBT) under the Ministry of Science and Technology and its PSU,...
COVID-19 Vaccines for patients treated for Lung Cancer with Immune checkpoint inhibitors Isra Zaman29 Jun 2022 9:30 AM ISTCancer patients have received priority status to receive COVID-19 vaccinations but there is limited data regarding the safety and efficacy of the...
CDSCO panel recommends emergency use nod for Gennova Biopharma mRNA COVID vaccine Ruchika Sharma28 Jun 2022 3:28 PM ISTThe vaccine - GEMCOVAC-19 - is the country's first homegrown mRNA COVID- 19 vaccine and is seen as a game-changer for the healthcare industry.
Pfizer-BioNTech omicron-adapted COVID vaccines demonstrate high immune response Ruchika Sharma27 Jun 2022 4:30 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
Valneva COVID vaccine gets marketing authorization in Europe Ruchika Sharma26 Jun 2022 10:00 AM ISTVLA2001 is the whole virus, inactivated, adjuvanted COVID-19 vaccine.
Fourth dose of Pfizer vaccine protects medicos against COVID-19 hospitalizations and deaths: JAMA Dr. Hiral patel24 Jun 2022 8:00 PM ISTIsrael: In residents of long-term care facilities (LTCFs), the fourth dose of the Pfizer BioNTech (BNT162b2) COVID-19 vaccine was associated with high...
WHO gives nod to Biological E as additional production site for JnJ COVID vaccine Ruchika Sharma23 Jun 2022 4:30 PM ISTIndia's first indigenously developed RBD protein subunit vaccine, Biological E's Corbevax, is currently being used to inoculate children in the age...
Merck Pneumococcal 15-valent Conjugate Vaccine gets USFDA nod for pediatric use Ruchika Sharma23 Jun 2022 12:45 PM ISTRahway: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (USFDA) has approved an...
